Functional Genome-wide Screen Identifies Pathways Restricting Central Nervous System Axonal Regeneration

Cell Reports, 2018 · DOI: 10.1016/j.celrep.2018.03.058 · Published: April 10, 2018

Simple Explanation

Researchers conducted a broad search to identify genes that prevent nerve cells in the brain and spinal cord from regrowing after injury. By turning off genes one by one, they found several pathways that, when blocked, allowed nerve fibers to regenerate. One important pathway involves protein transport within the cell. Specifically, a protein called Rab27b was found to limit nerve fiber regeneration. When Rab27b was removed, nerve regeneration improved in both worms and mice. These findings suggest new targets for therapies to promote nerve regeneration and recovery after injuries to the brain and spinal cord.

Study Duration

Not specified

Participants

Mice, C. elegans, primary mouse cortical neurons in vitro

Evidence Level

Level 2; Functional genomic screen, in vivo validation studies in C. elegans and mice

Key Findings

1
A genome-wide loss-of-function screen identified 580 genes that limit axonal regeneration from cerebral cortical neurons in vitro.
2
The screen revealed enrichment for genes in pathways related to transport, receptor binding, and cytokine signaling.
3
In vivo assessment with C. elegans and mice showed that loss of Rab27b enhances axonal regeneration after injury.

Research Summary

The study used a genome-wide loss-of-function screen to identify factors limiting axonal regeneration from cerebral cortical neurons in vitro, identifying 580 significant phenotypes. Key pathways identified include transport, receptor binding, and cytokine signaling, with Rab GTPases being prominent in transport regulation. In vivo validation in C. elegans and mice demonstrated that Rab27b restricts regeneration, and its absence leads to enhanced axonal regeneration and improved motor function after injury.

Practical Implications

Therapeutic Targets

The identified genes and pathways, particularly Rab27b, represent potential therapeutic targets for promoting axonal regeneration and functional recovery after CNS injuries.

Drug Development

Small-molecule inhibitors targeting identified regeneration-limiting proteins, such as Ship2, could be developed to enhance axonal regeneration.

Combination Therapies

Combining the suppression of multiple regeneration-limiting genes or pathways may lead to synergistic effects and improved outcomes after CNS injuries.

Study Limitations

1
The in vitro screen lacks the complex environmental contributions of the in vivo CNS.
2
The study focused on genes whose suppression stimulates regeneration, potentially overlooking genes required for endogenous regenerative potential.
3
The functional validation was primarily focused on Rab27b, and further in vivo studies are needed to validate the roles of other identified genes and pathways.

Your Feedback

Was this summary helpful?

Back to Neurology